1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNEI SBIR Cooperative Agreement for Early-Stage Clinical Trials is sponsored by National Eye Institute (NEI). Supports early-stage clinical trials for vision-related interventions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Concept Clearance – NEI Small Business Innovation Research (SBIR) Clinical Trial Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk | National Eye Institute Concept Clearance – NEI Small Business Innovation Research (SBIR) Clinical Trial Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk Program Lead/Presenter: Paek Lee, Ph. D.
, Program Director Council Date: June 16, 2023 The purpose of this initiative is to support SBIR grant applications from small business concerns that propose to implement investigator-initiated, early-stage clinical trials with greater than minimal risk and typically are Phase I or II trials. The risk level of the trials supported under this initiative requires appropriate performance oversight and safety monitoring.
For purposes of this initiative, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders. This initiative will support applications for SBIR clinical trials with the project period of 2 or 3 years, to investigate the safety and/or efficacy of screening, diagnostic, preventative, or therapeutic interventions.
This initiative will be specifically intended for early-stage clinical trials with greater than minimal risk, that have strong preliminary and/or pre-clinical data, a well-described Commercialization Plan, and clear delineation of milestones. Applications will be evaluated for scientific and technical merit by a Special Emphasis Panel convened by the NEI.
This initiative would fill in an important gap in the NEI Small Business Research Program portfolio and support greater than minimal risk human trials testing particularly in the following relevant areas 1. invasive ocular implants; 2. invasive surgical or diagnostic instruments; and 3.
early-stage trials of therapeutic drugs, biologics, and other devices. Last updated: December 31, 2024
According to the current listing, eligibility includes: Small businesses conducting early-stage clinical trials in vision research. Confirm the full requirements in the official notice before applying.
NEI SBIR Cooperative Agreement for Early-Stage Clinical Trials is funded by National Eye Institute (NEI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.